{"id":"https://openalex.org/W4391628366","doi":"https://doi.org/10.47671/tvg.60.17.5001960","title":"Optimalisatie van de antitumornecrosisfactor-alfa-behandeling bij inflammatoire darmziekten","display_name":"Optimalisatie van de antitumornecrosisfactor-alfa-behandeling bij inflammatoire darmziekten","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W4391628366","doi":"https://doi.org/10.47671/tvg.60.17.5001960"},"language":"nl","primary_location":{"id":"doi:10.47671/tvg.60.17.5001960","doi":"https://doi.org/10.47671/tvg.60.17.5001960","is_oa":false,"landing_page_url":"http://dx.doi.org/10.47671/tvg.60.17.5001960","pdf_url":null,"source":{"id":"https://openalex.org/S132598247","display_name":"Tijdschrift voor Geneeskunde","issn_l":"0371-683X","issn":["0371-683X","1784-9721"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4323237107","host_organization_name":"Universa BV","host_organization_lineage":["https://openalex.org/P4323237107"],"host_organization_lineage_names":["Universa BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tijdschrift voor Geneeskunde","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040659928","display_name":"B NAESSENS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"NAESSENS B","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007329495","display_name":"S VERMEIRE","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"VERMEIRE S","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000340576","display_name":"VAN ASSCHE G","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"VAN ASSCHE G","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5029712543","display_name":"P RUTGEERTS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RUTGEERTS P","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"17","first_page":"1247","last_page":"1255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.996999979019165},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.875},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9760000109672546},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9819999933242798},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/fistulizing-crohn-s-disease","display_name":"fistulizing Crohn's disease","score":0.9210000038146973},{"id":"https://openalex.org/keywords/luminal-crohn-s-disease","display_name":"luminal Crohn's disease","score":0.8510000109672546},{"id":"https://openalex.org/keywords/refractory-disease","display_name":"refractory disease","score":0.5920000076293945},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8289999961853027},{"id":"https://openalex.org/keywords/episodic-treatment","display_name":"episodic treatment","score":0.7689999938011169},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.8610000014305115},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9879999756813049},{"id":"https://openalex.org/keywords/6-mercaptopurine","display_name":"6-mercaptopurine","score":0.8840000033378601},{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.4950000047683716},{"id":"https://openalex.org/keywords/demyelinating-disorders","display_name":"demyelinating disease","score":0.9589999914169312},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cancer-risk","display_name":"cancer risk","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6268289089202881}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.47671/tvg.60.17.5001960","doi":"https://doi.org/10.47671/tvg.60.17.5001960","is_oa":false,"landing_page_url":"http://dx.doi.org/10.47671/tvg.60.17.5001960","pdf_url":null,"source":{"id":"https://openalex.org/S132598247","display_name":"Tijdschrift voor Geneeskunde","issn_l":"0371-683X","issn":["0371-683X","1784-9721"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4323237107","host_organization_name":"Universa BV","host_organization_lineage":["https://openalex.org/P4323237107"],"host_organization_lineage_names":["Universa BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tijdschrift voor Geneeskunde","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2135423184","https://openalex.org/W2115836767","https://openalex.org/W2027696892","https://openalex.org/W111350203","https://openalex.org/W2128230250","https://openalex.org/W4240725837","https://openalex.org/W1981122777","https://openalex.org/W181166195","https://openalex.org/W2029259751","https://openalex.org/W2517443738"],"abstract_inverted_index":{"Auteur(s):":[0],"NAESSENS":[1],"B,":[2],"VERMEIRE":[3],"S,":[4],"VAN":[5],"ASSCHE":[6],"G,":[7],"RUTGEERTS":[8],"P":[9],"|":[10],"Samenvatting:":[11],"Infliximab,":[12],"een":[13,45,81,103,192],"chimerische":[14],"monoklonale":[15],"anti-TNF-a-antistof,":[16],"is":[17,39,80,87,102,107,126,184],"aangewezen":[18],"voor":[19,51],"de":[20,68,93,114,147,166,180,196],"behandeling":[21,86,97,123],"van":[22,26,29,32,47,56,90,100,116,142,149,155,168,188,199,207,217,220],"therapieresistente":[23],"luminale":[24,37],"ziekte":[25,31,38,55,148,204],"Crohn":[27,57],"of":[28,131],"fistuliserende":[30,54],"Crohn.":[33],"Voor":[34],"pati\u00ebnten":[35,52,70,158],"met":[36,53,113,159,176,185,191],"\u00e9\u00e9n":[40],"enkel":[41],"infuus":[42],"infliximab":[43,91,119,143,156,177],"aan":[44],"dosis":[46],"5":[48],"mg/kg":[49],"effici\u00ebnt;":[50],"worden":[58],"drie":[59],"infusen":[60],"(week":[61],"0,":[62],"2":[63],"en":[64,110,165,190,205],"6)":[65],"aangeraden.":[66],"Aangezien":[67],"meeste":[69],"na":[71],"ongeveer":[72],"8":[73,94],"tot":[74],"12":[75],"weken":[76],"nieuwe":[77],"symptomen":[78,99],"ontwikkelen,":[79],"langetermijnstrategie":[82],"noodzakelijk.":[83,133],"De":[84],"optimale":[85],"systematische":[88],"toediening":[89],"om":[92],"weken.":[95],"Episodische":[96],"bij":[98,146,157],"recidief":[101],"andere":[104],"mogelijkheid,":[105],"doch":[106],"minder":[108],"effici\u00ebnt":[109],"vaak":[111],"geassocieerd":[112,183],"vorming":[115],"antistoffen":[117],"tegen":[118,164],"(ATI).":[120],"Wanneer":[121],"episodische":[122],"wordt":[124],"gegeven,":[125],"concomitante":[127],"immunosuppressieve":[128],"therapie":[129],"(azathioprine/6-mercaptopurine":[130],"methotrexaat)":[132],"Er":[134,210],"zijn":[135,216],"nog":[136],"geen":[137,212],"gegevens":[138,151],"over":[139,152],"het":[140,153,186,218],"gebruik":[141,154],"als":[144],"eerstelijnsbehandeling":[145],"Crohn.De":[150],"colitis":[160],"ulcerosa":[161],"spreken":[162],"elkaar":[163],"resultaten":[167],"grote":[169],"gecontroleerde":[170],"studies":[171],"dienen":[172],"afgewacht":[173],"te":[174,215],"worden.Problemen":[175],"omvatten":[178,201],"grotendeels":[179],"antistofvorming":[181],"die":[182],"optreden":[187],"infuusreacties":[189],"verminderde":[193],"respons":[194],"op":[195],"behandeling.":[197],"Neveneffecten":[198],"anti-TNF-a-behandeling":[200],"tuberculose,":[202],"demyeliniserende":[203],"verergering":[206],"congestief":[208],"hartfalen.":[209],"lijkt":[211],"verhoogd":[213],"risico":[214],"ontstaan":[219],"maligniteiten.":[221]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2024-02-08T00:00:00"}